News
Subscribe to the Australian BioCommons monthly newsletter or read previous editions
World-leading Australian science: 17M protein structures added to the AlphaFold Database to accelerate the fight against antimicrobial resistance
Australian researcher, George Bouras, has recently contributed an extraordinary 17 million protein predictions to the AlphaFold Protein Structure Database. This work was possible thanks to the availability of the ColabFold tool on Setonix AMD, the result of collaboration between BioCommons and the Pawsey Supercomputing Research Centre.
Multi-model 3D visualisation enhances Nextflow pipeline for protein structure prediction
Community driven enhancements to Nextflows’ nf-core proteinfold pipeline have simplified the parallel execution, visualisation and comparison of multiple models for protein structure prediction including AlphaFold2, ColabFold, ESMFold.
An Australian community for computational structural biology
A passionate group of structural biologists has formed the Australian Structural Biology Computing Community, to share computational knowledge, methods, and resources.
Repurposed hardware boosts national capacity and powers innovation
QCIF Ltd has made high-performance hardware available to the Australian BioCommons, giving the hardware a second life and uplifting national capacity for running AlphaFold 2 jobs in Galaxy Australia while supporting innovation through other GPU-enabled tools.
Creative collisions: Bio Day a hit at Supercomputing Asia 2024
Learn more the dedicated ‘Bio Day’ at SCA, which focused on the intersection of biology and computing.
Launching the Australian AlphaFold Service
A new service is now offering researchers the chance to accelerate their research through access to AlphaFold. The Australian AlphaFold Service delivers AlphaFold through Galaxy Australia, offering an easy to use interface coupled with the required computational resources at no cost to Australian researchers.
Uncovering the secrets of parasites through AI and Cloud computing
A partnership between Australian BioCommons and Microsoft has resulted in University of Melbourne researchers being able to quickly leverage new methods through a large grant to use the Azure Cloud, with significant implications for the research community worldwide.